药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methyprylon
Guselkumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Guselkumab.
Methyprylon
Baricitinib
The risk or severity of adverse effects can be increased when Belinostat is combined with Baricitinib.
Methyprylon
Sirukumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Sirukumab.
Methyprylon
Brodalumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Brodalumab.
Methyprylon
Peficitinib
The risk or severity of adverse effects can be increased when Belinostat is combined with Peficitinib.
Methyprylon
Voclosporin
The risk or severity of adverse effects can be increased when Belinostat is combined with Voclosporin.
Methyprylon
Pirarubicin
The risk or severity of adverse effects can be increased when Belinostat is combined with Pirarubicin.
Methyprylon
Ravulizumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Ravulizumab.
Methyprylon
Ixekizumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Ixekizumab.
Methyprylon
Melengestrol
The risk or severity of adverse effects can be increased when Belinostat is combined with Melengestrol.
Methyprylon
Tepoxalin
The risk or severity of adverse effects can be increased when Belinostat is combined with Tepoxalin.
Methyprylon
Fluprednisolone
The risk or severity of adverse effects can be increased when Belinostat is combined with Fluprednisolone.
Methyprylon
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Belinostat is combined with Antilymphocyte immunoglobulin (horse).
Methyprylon
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Belinostat is combined with Peginterferon beta-1a.
Methyprylon
Tixocortol
The risk or severity of adverse effects can be increased when Belinostat is combined with Tixocortol.
Methyprylon
Vilanterol
The risk or severity of adverse effects can be increased when Belinostat is combined with Vilanterol.
Methyprylon
Dinutuximab
The risk or severity of adverse effects can be increased when Belinostat is combined with Dinutuximab.
Methyprylon
Idelalisib
The risk or severity of adverse effects can be increased when Belinostat is combined with Idelalisib.
Methyprylon
Ibrutinib
The risk or severity of adverse effects can be increased when Belinostat is combined with Ibrutinib.
Methyprylon
Blinatumomab
The risk or severity of adverse effects can be increased when Belinostat is combined with Blinatumomab.